Your browser is no longer supported. Please, upgrade your browser.
Settings
CDXS Codexis, Inc. daily Stock Chart
CDXS [NASD]
Codexis, Inc.
Index- P/E- EPS (ttm)-0.26 Insider Own3.70% Shs Outstand58.01M Perf Week-5.66%
Market Cap754.71M Forward P/E- EPS next Y-0.11 Insider Trans-6.74% Shs Float56.18M Perf Month-29.41%
Income-14.10M PEG- EPS next Q-0.09 Inst Own87.00% Short Float6.89% Perf Quarter-31.60%
Sales60.90M P/S12.39 EPS this Y83.10% Inst Trans7.49% Short Ratio9.73 Perf Half Y-40.32%
Book/sh1.80 P/B7.23 EPS next Y52.20% ROA-13.90% Target Price23.50 Perf Year-13.55%
Cash/sh1.61 P/C8.08 EPS next 5Y15.00% ROE-21.60% 52W Range12.81 - 23.05 Perf YTD-22.10%
Dividend- P/FCF- EPS past 5Y28.00% ROI-20.00% 52W High-43.04% Beta0.11
Dividend %- Quick Ratio6.30 Sales past 5Y13.70% Gross Margin78.10% 52W Low2.53% ATR0.63
Employees132 Current Ratio6.30 Sales Q/Q-8.90% Oper. Margin-24.00% RSI (14)21.04 Volatility4.40% 4.27%
OptionableYes Debt/Eq0.00 EPS Q/Q-67.30% Profit Margin-23.10% Rel Volume0.98 Prev Close13.01
ShortableYes LT Debt/Eq0.00 EarningsAug 06 AMC Payout- Avg Volume397.91K Price13.13
Recom1.80 SMA20-17.03% SMA50-24.72% SMA200-29.78% Volume261,065 Change0.92%
Jan-17-19Upgrade First Analysis Sec Neutral → Outperform $12 → $19
May-16-18Initiated Stephens Overweight $16
Oct-13-17Reiterated H.C. Wainwright Buy $8 → $8.50
May-31-17Initiated Jefferies Buy $8
Jan-26-17Downgrade First Analysis Sec Overweight → Equal-Weight $5.50
Jan-04-17Upgrade Ladenburg Thalmann Neutral → Buy
Jan-06-16Initiated H.C. Wainwright Buy $6
Aug-09-19 01:32PM  Edited Transcript of CDXS earnings conference call or presentation 6-Aug-19 8:30pm GMT Thomson Reuters StreetEvents
Aug-07-19 03:49PM  Codexis Rolls Into Second Half Armed with Cash Motley Fool -16.07%
08:25AM  Codexis(CDXS) Q2 2019 Earnings Call Transcript Motley Fool
Aug-06-19 07:35PM  Codexis (CDXS) Reports Q2 Loss, Lags Revenue Estimates Zacks
04:06PM  Codexis Reports Second Quarter 2019 Financial Results GlobeNewswire
Jul-30-19 07:00AM  Codexis to Hold Second Quarter 2019 Conference Call on August 6 GlobeNewswire
Jun-27-19 03:01PM  3 Top Stocks Under $20 Motley Fool
Jun-20-19 07:00AM  Casdin Capital Invests $50 Million in Codexis to Accelerate Strategic Growth Initiatives GlobeNewswire
Jun-10-19 12:06PM  Is Codexis a Buy? Motley Fool
May-30-19 07:00AM  Codexis to Present at the Jefferies 2019 Global Healthcare Conference GlobeNewswire
May-16-19 09:34AM  Who Has Been Selling Codexis, Inc. (NASDAQ:CDXS) Shares? Simply Wall St.
May-15-19 09:00AM  Codexis Announces CodeEvolver® Technology Transfer and License Agreement with Global Pharmaceutical Leader GlobeNewswire
May-14-19 04:05PM  Codexis to Participate at Three Investment Conferences in May GlobeNewswire
May-10-19 01:51AM  Edited Transcript of CDXS earnings conference call or presentation 6-May-19 8:30pm GMT Thomson Reuters StreetEvents
May-09-19 10:07AM  Codexis Bags Novartis as Software Customer, Stays Course in First Quarter Motley Fool
May-07-19 10:57AM  Hedge Funds Have Never Been This Bullish On Codexis, Inc. (CDXS) Insider Monkey -6.55%
03:23AM  Codexis(CDXS) Q1 2019 Earnings Call Transcript Motley Fool
May-06-19 07:25PM  Codexis (CDXS) Reports Q1 Loss, Tops Revenue Estimates Zacks
06:19PM  Codexis: 1Q Earnings Snapshot Associated Press
04:06PM  Codexis Reports First Quarter 2019 Financial Results GlobeNewswire
Apr-30-19 10:54AM  3 Stocks That Could Help You Send Your Kids to College Motley Fool
07:00AM  Codexis Signs Multi-Year Enzyme Supply and Licensing Agreement with Tate & Lyle for the Manufacture of TASTEVA® M Stevia Sweetener GlobeNewswire
Apr-29-19 07:00AM  Codexis to Hold First Quarter 2019 Conference Call on May 6 GlobeNewswire
Apr-19-19 02:09PM  Investors Who Bought Codexis (NASDAQ:CDXS) Shares Five Years Ago Are Now Up 1053% Simply Wall St.
Apr-05-19 04:05PM  Codexis Senior Vice President of R&D Dr. Jim Lalonde Announces Plan to Resign GlobeNewswire
Mar-22-19 09:41AM  3 Stocks Poised for Huge Growth Over the Next Decade Motley Fool -6.03%
Mar-14-19 11:15AM  Codexis (CDXS) Q4 Earnings Beat Estimates Zacks
Mar-07-19 01:25PM  Codexis, Inc. (NASDAQ:CDXS) Is Expected To Breakeven Simply Wall St.
Mar-05-19 07:00AM  Codexis to Participate in Two Investment Conferences in March GlobeNewswire
Mar-02-19 11:48AM  Codexis Inc (CDXS) Files 10-K for the Fiscal Year Ended on December 31, 2018 GuruFocus.com
Mar-01-19 07:45AM  Analysis: Positioning to Benefit within Synchrony Financial, KKR & Co., Life Storage, Unum Group, Codexis, and Finisar Research Highlights Growth, Revenue, and Consolidated Results GlobeNewswire
06:57AM  Edited Transcript of CDXS earnings conference call or presentation 26-Feb-19 9:30pm GMT Thomson Reuters StreetEvents
Feb-27-19 10:18AM  Codexis Hits the Mark in 2018, Expects Revenue to Climb 16% in 2019 Motley Fool
Feb-26-19 08:14PM  Codexis Inc (CDXS) Q4 2018 Earnings Conference Call Transcript Motley Fool
04:05PM  Codexis Reports 2018 Fourth Quarter and Full Year Financial Results GlobeNewswire
Feb-25-19 07:00AM  Codexis Names Laurie Heilmann Senior Vice President of Business Development and Marketing GlobeNewswire
Feb-23-19 09:13AM  3 Stocks the World's Best Investors Are Buying Right Now Motley Fool
Feb-19-19 07:00AM  Codexis to Hold 2018 Fourth Quarter and Full Year Conference Call on February 26 GlobeNewswire
Feb-14-19 07:00AM  Codexis Announces Nestlé Health Science Exercises Option for Exclusive Global License to CDX-6114 for the Management of Phenylketonuria GlobeNewswire
Feb-06-19 07:00AM  Codexis Announces Enzyme Supply Agreement with KYORIN Pharmaceutical for Overactive Bladder Drug Sold in Japan GlobeNewswire
Feb-05-19 04:36PM  A Pact With Merck Sent This Biotech Stock Zooming Near A Breakout Investor's Business Daily +6.09%
03:44PM  Here's Why Codexis Gained as Much as 9.8% Today Motley Fool
07:47AM  The Daily Biotech Pulse: Gilead Earnings, Codexis Sings Pact With Merck, Eli Lilly Reports Positive Trial Results Benzinga
Feb-04-19 04:05PM  Codexis Secures Multi-Year Technology Upgrade Package for its CodeEvolver Protein Engineering Platform License with Merck GlobeNewswire
Jan-30-19 06:00PM  3 Top Stocks Under $20 Motley Fool
Jan-14-19 05:04PM  2 Top Small-Cap Stocks to Buy in January Motley Fool
Jan-02-19 10:55AM  Do Institutions Own Codexis, Inc. (NASDAQ:CDXS) Shares? Simply Wall St.
Dec-05-18 06:18PM  Edited Transcript of CDXS earnings conference call or presentation 8-Nov-18 9:30pm GMT Thomson Reuters StreetEvents
Nov-28-18 08:45AM  Report: Developing Opportunities within Costco Wholesale, Pepsico, Northern Oil and Gas, Codexis, Sangamo Therapeutics, and BRF S.A. Future Expectations, Projections Moving into 2018 GlobeNewswire +7.18%
Nov-14-18 02:39PM  This Small-Cap Biotech is Quietly Setting the Stage For a Big 2019 Motley Fool
Nov-13-18 12:11PM  Should You Worry About Codexis Incs (NASDAQ:CDXS) CEO Pay? Simply Wall St.
Nov-08-18 07:20PM  Codexis (CDXS) Reports Break-Even Earnings for Q3 Zacks
06:16PM  Codexis: 3Q Earnings Snapshot Associated Press
04:05PM  Codexis Reports Third Quarter 2018 Financial Results GlobeNewswire
07:00AM  Codexis Announces Results of Phase 1a Clinical Trial with CDX-6114 GlobeNewswire
Nov-07-18 04:05PM  Codexis to Present at Two Investment Conferences in November GlobeNewswire +6.34%
Nov-01-18 11:28AM  Will Codexis (CDXS) Report Negative Earnings Next Week? What You Should Know Zacks
07:00AM  Codexis to Hold Third Quarter 2018 Conference Call on November 8 GlobeNewswire
Oct-17-18 07:20AM  Investor Expectations to Drive Momentum within Arsanis, Dynavax Technologies, Puma Biotechnology, Opko Health, Adaptimmune Therapeutics, and Codexis Discovering Underlying Factors of Influence GlobeNewswire
Oct-06-18 08:35AM  Better Synthetic Biology Stock: Amyris vs. Codexis Motley Fool
Oct-01-18 07:00AM  Codexis Appoints Claus Ladefoged to Global Enzyme Business Development Role GlobeNewswire
Sep-12-18 04:27PM  Edited Transcript of CDXS earnings conference call or presentation 8-Aug-18 8:30pm GMT Thomson Reuters StreetEvents
Sep-11-18 07:11AM  The Zacks Analyst Blog Highlights: AeroVironment, BioSpecifics, Codexis, Avid and American Outdoor Zacks
Sep-10-18 09:23AM  5 Top-Ranked Nasdaq Stocks Defying the Worst September Start Zacks
Sep-05-18 02:33PM  Codexis Inc (NASDAQ:CDXS): Did It Outperform The Industry? Simply Wall St.
Sep-04-18 03:31PM  Here's Why Codexis Gained 19.4% in August Motley Fool
Aug-29-18 07:00AM  Codexis to Present at Three Investment Conferences in September GlobeNewswire
Aug-20-18 08:10AM  Report: Exploring Fundamental Drivers Behind Codexis, Kornit Digital, NewLink Genetics, NCS Multistage, Mountain Province Diamonds, and CSS Industries New Horizons, Emerging Trends, and Upcoming Developments GlobeNewswire
Aug-17-18 12:50PM  4 Under-the-Radar Small Cap Stars Investopedia
Aug-15-18 09:58AM  E-commerce, Favorable Markets Drive Growth at Grainger (GWW) Zacks
Aug-08-18 08:55PM  Codexis (CDXS) Reports Q2 Loss, Tops Revenue Estimates Zacks
07:48PM  Codexis: 2Q Earnings Snapshot Associated Press
04:05PM  Codexis Reports Second Quarter 2018 Financial Results GlobeNewswire
02:30PM  Codexis, Inc. to Host Earnings Call ACCESSWIRE
Aug-01-18 07:00AM  Codexis to Hold Second Quarter 2018 Conference Call on August 8 GlobeNewswire
Jul-11-18 07:00AM  Codexis Appoints Dr. Hicham Alaoui, Veteran Drug Discoverer, as Vice President, Biotherapeutics Research & Development GlobeNewswire
Jul-09-18 08:00AM  Codexis Doses First Subjects in Phase 1a Trial of CDX-6114 GlobeNewswire
Jul-06-18 07:20AM  Free Technical Research on Clovis Oncology and Three More Biotech Equities ACCESSWIRE
Jun-21-18 08:19AM  3 Growth Stocks I'd Buy Right Now Motley Fool
Jun-16-18 08:46AM  3 Stocks That Could Put Tesla's Returns to Shame Motley Fool
Jun-01-18 08:00AM  New Research Coverage Highlights WPP, Codexis, Natural Resource Partners LP, Mercer International, Booking, and SINOPEC Shangai Petrochemical Consolidated Revenues, Company Growth, and Expectations for 2018 GlobeNewswire
May-29-18 07:00AM  Codexis to Present at Three Upcoming Investment Conferences GlobeNewswire
May-18-18 04:12AM  Edited Transcript of CDXS earnings conference call or presentation 10-May-18 8:30pm GMT Thomson Reuters StreetEvents
May-11-18 08:11PM  3 High-Growth Stocks That Are Just Getting Started Motley Fool +8.58%
May-10-18 06:40PM  Codexis: 1Q Earnings Snapshot Associated Press
04:05PM  Codexis Reports First Quarter 2018 Financial Results GlobeNewswire
May-03-18 07:00AM  Codexis to Hold First Quarter 2018 Conference Call on May 10 GlobeNewswire
Apr-25-18 07:40AM  Blog Exposure - Codexis Entered into Strategic Collaboration with Porton Pharma Solutions ACCESSWIRE
Apr-23-18 06:00AM  Porton Pharma Solutions and Codexis Launch Global Partnership Business Wire
Apr-09-18 08:10AM  New Research Coverage Highlights Alliance Resource Partners, MyoKardia, Pan American Silver, Stitch Fix, Codexis, and Chemical Financial Consolidated Revenues, Company Growth, and Expectations for 2018 GlobeNewswire
Apr-06-18 11:08AM  Why Codexis, Inc. Stock Is Tumbling Today Motley Fool
Apr-05-18 09:15PM  Codexis Announces Pricing of Public Offering of Common Stock GlobeNewswire
04:02PM  Codexis Announces Proposed Public Offering of Common Stock GlobeNewswire
07:00AM  Codexis to Present at H.C. Wainwright Global Life Sciences Conference in Monte Carlo, Monaco GlobeNewswire
Mar-30-18 03:26PM  Edited Transcript of CDXS earnings conference call or presentation 8-Mar-18 9:30pm GMT Thomson Reuters StreetEvents
Mar-25-18 06:35AM  3 Stocks That Feel Like Microsoft in 1986 Motley Fool
Mar-13-18 08:10AM  Detailed Research: Economic Perspectives on GRIDSUM HOLDING, Booking, POSCO, Codexis, Third Point Reinsurance, and Arch Capital Group What Drives Growth in Today's Competitive Landscape GlobeNewswire
Mar-09-18 03:16PM  Here's Why Codexis Dropped as Much as 14.6% Today Motley Fool
Mar-08-18 06:07PM  Codexis misses Street 4Q forecasts Associated Press
04:05PM  Codexis Reports 2017 Fourth Quarter and Full Year Financial Results GlobeNewswire
Codexis, Inc. discovers, develops, and sells protein catalysts. It also offers intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides protein catalyst screening and protein engineering services. In addition, it offers CodeEvolver protein engineering technology platform, which helps in developing and delivering protein catalysts that perform chemical transformations. The company's platform is used to discover novel biotherapeutic drug candidates for targeted human diseases, as well as for molecular biology and in vitro diagnostic enzymes. Its platform also enhances the pharmaceuticals companies manufacturing productivity and efficiency or outsourcing the manufacture of the intermediates and active pharmaceutical ingredients. The company sells its products to pharmaceutical manufacturers through its direct sales and business development force in the United States and Europe. Codexis, Inc. was founded in 2002 and is headquartered in Redwood City, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Lalonde JamesSVP, R&DMay 14Option Exercise7.462,37817,740135,780May 15 04:23 PM
Lalonde JamesSVP, R&DMay 14Sale18.952,37845,060133,402May 15 04:23 PM
Lalonde JamesSVP, R&DMay 13Option Exercise7.4617,621131,453151,023May 15 04:23 PM
Lalonde JamesSVP, R&DMay 13Sale18.6117,621327,955133,402May 15 04:23 PM
SANGSTER GORDONSVP & Chief Financial OfficerMar 21Option Exercise4.1040,000164,000174,453Mar 22 06:25 PM
SANGSTER GORDONSVP & Chief Financial OfficerMar 21Sale20.9140,000836,204134,453Mar 22 06:25 PM
SANGSTER GORDONSVP & Chief Financial OfficerMar 20Option Exercise3.3940,000135,600174,453Mar 22 06:25 PM
SANGSTER GORDONSVP & Chief Financial OfficerMar 20Sale20.8540,000834,012134,453Mar 22 06:25 PM
NICOLS JOHN JPresident and CEOMar 19Option Exercise3.4640,000138,4001,112,679Mar 20 05:30 PM
NICOLS JOHN JPresident and CEOMar 19Sale20.7940,000831,5041,072,679Mar 20 05:30 PM
NICOLS JOHN JPresident and CEOMar 18Option Exercise3.4615,07252,1491,087,751Mar 20 05:30 PM
NICOLS JOHN JPresident and CEOMar 18Sale20.9515,072315,7161,072,679Mar 20 05:30 PM
SANGSTER GORDONSVP & Chief Financial OfficerJan 25Option Exercise3.3940,000135,600174,453Jan 28 06:00 PM
SANGSTER GORDONSVP & Chief Financial OfficerJan 25Sale17.1140,000684,236134,453Jan 28 06:00 PM
SANGSTER GORDONSVP & Chief Financial OfficerJan 24Option Exercise3.3935,000118,650169,453Jan 28 06:00 PM
SANGSTER GORDONSVP & Chief Financial OfficerJan 24Sale16.7435,000585,942134,453Jan 28 06:00 PM
BARUCH THOMAS RDirectorDec 28Sale15.9812,500199,725103,093Dec 31 07:14 PM
BARUCH THOMAS RDirectorDec 27Sale16.0912,500201,076115,593Dec 31 07:14 PM
WOLF DENNIS PDirectorDec 26Sale15.839,000142,42586,230Dec 28 08:17 PM
KELLEY BERNARD JDirectorDec 21Sale16.9810,206173,316205,255Dec 26 05:15 PM
Yang Patrick YDirectorDec 20Sale17.8225,000445,49253,817Dec 21 06:39 PM
Yang Patrick YDirectorDec 19Sale19.2225,000480,45878,817Dec 21 06:39 PM
NICOLS JOHN JPresident and CEODec 07Option Exercise3.463,81213,1901,076,491Dec 10 05:36 PM
NICOLS JOHN JPresident and CEODec 07Sale22.093,81284,2091,072,679Dec 10 05:36 PM
NICOLS JOHN JPresident and CEODec 06Option Exercise3.4640,000138,4001,112,679Dec 10 05:36 PM
NICOLS JOHN JPresident and CEODec 06Sale21.7540,000869,8321,072,679Dec 10 05:36 PM
Lalonde JamesSVP, R&DNov 13Sale15.226,726102,395151,317Nov 14 07:11 PM
Lalonde JamesSVP, R&DNov 12Sale15.576,727104,716158,043Nov 14 07:11 PM
SANGSTER GORDONSVP & Chief Financial OfficerOct 03Option Exercise17.1140,000684,516174,453Oct 04 06:36 PM
SANGSTER GORDONSVP & Chief Financial OfficerOct 03Sale17.1140,000684,516134,453Oct 04 06:36 PM
SANGSTER GORDONSVP & Chief Financial OfficerOct 02Option Exercise16.7640,000670,476174,453Oct 04 06:36 PM
SANGSTER GORDONSVP & Chief Financial OfficerOct 02Sale16.7640,000670,476134,453Oct 04 06:36 PM
NICOLS JOHN JPresident and CEOSep 28Option Exercise3.4640,000138,4001,112,679Oct 01 09:52 PM
NICOLS JOHN JPresident and CEOSep 28Sale17.4340,000697,3241,072,679Oct 01 09:52 PM
NICOLS JOHN JPresident and CEOSep 27Option Exercise3.4640,000138,4001,112,679Oct 01 09:52 PM
NICOLS JOHN JPresident and CEOSep 27Sale17.7140,000708,3491,072,679Oct 01 09:52 PM
BARUCH THOMAS RDirectorSep 27Sale18.0712,500225,904128,093Sep 28 07:42 PM
BARUCH THOMAS RDirectorSep 26Sale19.0012,500237,489140,593Sep 28 07:42 PM
WOLF DENNIS PDirectorSep 26Sale19.179,000172,52295,230Sep 28 07:46 PM
Glaub Kathleen SeredaDirectorSep 25Sale18.8314,492272,81663,534Sep 27 05:18 PM
KELLEY BERNARD JDirectorSep 21Sale18.1210,207184,959215,461Sep 25 09:19 PM
Glaub Kathleen SeredaDirectorSep 19Sale17.9420,094360,39078,026Sep 20 06:40 PM
Yang Patrick YDirectorSep 19Sale17.9425,000448,428103,817Sep 20 06:30 PM
Yang Patrick YDirectorSep 18Sale18.4725,000461,750128,817Sep 20 06:30 PM
Lalonde JamesSVP, R&DSep 05Sale17.3512,381214,849164,770Sep 06 05:17 PM
Lalonde JamesSVP, R&DSep 04Sale17.1617,915307,348177,151Sep 06 05:17 PM
KELLEY BERNARD JDirectorAug 30Option Exercise7.4616,666124,328242,334Sep 04 09:03 PM
KELLEY BERNARD JDirectorAug 30Sale17.1516,666285,780225,668Sep 04 09:03 PM